Zobrazeno 1 - 10
of 1 647
pro vyhledávání: '"Boesche M"'
Autor:
Quasebarth M; Ci3, Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, USA., Boesche M; Crown Family School of Social Work, Policy, and Practice, University of Chicago, Chicago, Illinois, USA., Turner T; Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA., Moore A; Ci3, Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, USA., Young D; Planned Parenthood of Illinois, Chicago, Illinois, USA., Stulberg D; Department of Family Medicine, University of Chicago, Chicago, Illinois, USA., Hasselbacher L; Ci3, Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, USA.
Publikováno v:
Perspectives on sexual and reproductive health [Perspect Sex Reprod Health] 2024 Apr 11. Date of Electronic Publication: 2024 Apr 11.
Autor:
Sebastian M; Department of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Frankfurt, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt, Germany., Eberhardt WEE; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Division of Thoracic Oncology, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, Essen, Germany., von der Heyde E; Onkologische Schwerpunktpraxis, Hannover, Germany., Dörfel S; Onkozentrum Dresden/Freiberg, Dresden, Germany., Wiegand J; Gemeinschaftspraxis für Hämatologie & Onkologie, Moers, Germany., Schiefer C; Pneumologie Markkleeberg GbR, Markkleeberg, Germany., Losem C; TZN-Tumorzentrum Niederrhein GmbH, Neuss, Germany., Jänicke M; Clinical Epidemiology and Health Economics, iOMEDICO, Freiburg i. Br, Germany., Fleitz A; Clinical Epidemiology and Health Economics, iOMEDICO, Freiburg i. Br, Germany., Zacharias S; Biostatistics, iOMEDICO, Freiburg i. Br, Germany., Kaiser-Osterhues A; Medical Department, iOMEDICO, Freiburg i. Br, Germany., Hipper A; AIO-Studien-gGmbH, Berlin, Germany., Dietel C; AIO-Studien-gGmbH, Berlin, Germany., Bleckmann A; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Benkelmann R; Innere Medizin/Hämatoonkologie/Gastroenterologie/Palliativmedizin, I. Med. Klinik, Konstanz, Germany., Boesche M; Pneumologie, Klinik für Innere Medizin B, Universitätsmedizin Greifswald, Greifswald, Germany., Grah C; Pneumologie-Lungenkrebszentrum, Gemeinschaftskrankenhaus Havelhöhe, Berlin, Germany., Müller A; Marienhof Koblenz, Katholisches Klinikum Koblenz Montabaur, Koblenz, Germany., Griesinger F; Department of Hematology and Oncology, University Department Internal Medicine-Oncology, Pius-Hospital, University Medicine Oldenburg, Oldenburg, Germany., Thomas M; Department of Thoracic Oncology, Thoraxklinik, University Hospital Heidelberg and Translational, Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Jun 01; Vol. 154 (11), pp. 1967-1978. Date of Electronic Publication: 2024 Feb 08.
Autor:
Sebastian, M., Griesinger, F., von der Heyde, E., Dörfel, S., Wiegand, J., Schiefer, C., Losem, C., Jänicke, M., Fleitz, A., Zacharias, S., Hipper, A., Dietel, C., Bleckmann, A., Benkelmann, R., Boesche, M., Grah, C., Müller, A., Eberhardt, Wilfried E. E., Thomas, M.
Poster-Abstract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=unidue___bib::80e0faac95f3795d21de4c6d5a7bd425
Autor:
Wyllie S; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Thomas M; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Patterson S; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Crouch S; Global Health R&D, GlaxoSmithKline, Tres Cantos, Spain., De Rycker M; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Lowe R; David Jack Centre for R&D, GlaxoSmithKline, Ware, UK., Gresham S; David Jack Centre for R&D, GlaxoSmithKline, Ware, UK., Urbaniak MD; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.; Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, UK., Otto TD; Wellcome Sanger Institute, Cambridge, UK.; Centre of Immunobiology, Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Stojanovski L; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Simeons FRC; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Manthri S; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., MacLean LM; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Zuccotto F; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Homeyer N; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Pflaumer H; Cellzome GmbH, A GlaxoSmithKline Company, Heidelberg, Germany., Boesche M; Cellzome GmbH, A GlaxoSmithKline Company, Heidelberg, Germany., Sastry L; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Connolly P; GlaxoSmithKline, New Frontiers Science Park, Harlow, UK., Albrecht S; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Berriman M; Wellcome Sanger Institute, Cambridge, UK., Drewes G; Cellzome GmbH, A GlaxoSmithKline Company, Heidelberg, Germany., Gray DW; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Ghidelli-Disse S; Cellzome GmbH, A GlaxoSmithKline Company, Heidelberg, Germany., Dixon S; Global Health R&D, GlaxoSmithKline, Stockley Park West, Uxbridge, UK., Fiandor JM; Global Health R&D, GlaxoSmithKline, Tres Cantos, Spain., Wyatt PG; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Ferguson MAJ; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Fairlamb AH; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK., Miles TJ; Global Health R&D, GlaxoSmithKline, Tres Cantos, Spain. tim.j.miles@gsk.com., Read KD; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK. k.read@dundee.ac.uk., Gilbert IH; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK. i.h.gilbert@dundee.ac.uk.
Publikováno v:
Nature [Nature] 2023 Jul; Vol. 619 (7970), pp. E48.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ralf E; Division of Pneumology, Department of Internal Medicine B, University Hospital Greifswald, F.-Sauerbruchstrasse, 17489, Greifswald, Germany., Heine A; Division of Pneumology, Department of Internal Medicine B, University Hospital Greifswald, F.-Sauerbruchstrasse, 17489, Greifswald, Germany., Obst A; Division of Pneumology, Department of Internal Medicine B, University Hospital Greifswald, F.-Sauerbruchstrasse, 17489, Greifswald, Germany., Koerner K; Division of Pneumology, Department of Internal Medicine B, University Hospital Greifswald, F.-Sauerbruchstrasse, 17489, Greifswald, Germany., Hustig-Kittler V; Division of Pneumology, Department of Internal Medicine B, University Hospital Greifswald, F.-Sauerbruchstrasse, 17489, Greifswald, Germany., Boesche M; Division of Pneumology, Department of Internal Medicine B, University Hospital Greifswald, F.-Sauerbruchstrasse, 17489, Greifswald, Germany., Elhadad M; Division of Pneumology, Department of Internal Medicine B, University Hospital Greifswald, F.-Sauerbruchstrasse, 17489, Greifswald, Germany., Stubbe B; Division of Pneumology, Department of Internal Medicine B, University Hospital Greifswald, F.-Sauerbruchstrasse, 17489, Greifswald, Germany. beate.stubbe@med.uni-greifswald.de., Westhoff M; Center for Pneumology and Thoracic Surgery, Lung Clinic Hemer, Hemer, Germany.; Witten/Herdecke University, Witten, Germany.
Publikováno v:
Scientific reports [Sci Rep] 2023 Apr 21; Vol. 13 (1), pp. 6586. Date of Electronic Publication: 2023 Apr 21.
Publikováno v:
Pneumologie; 2024 Supplement 1, Vol. 78, pS103-S104, 2p
Publikováno v:
In Contraception December 2022 116:78-78
Autor:
Sebastian, M., Griesinger, F., von der Heyde, E., Dörfel, S., Wiegand, J.H., Schiefer, C., Losem, C., Jänicke, M., Fleitz, A., Zacharias, S., Hipper, A., Dietel, C., Bleckmann, A., Benkelmann, R., Boesche, M., Grah, C., Müller, A., Eberhardt, W.E.E., Thomas, M.
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S1080-S1081
Autor:
Flipo M; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France., Frita R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Bourotte M; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; BioVersys SAS, Lille, France., Martínez-Martínez MS; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Boesche M; Cellzome GmbH . A GSK Company, 69117 Heidelberg, Germany., Boyle GW; GSK, David Jack Centre for R&D, Park Road, Ware, Hertfordshire SG12 ODP, UK., Derimanov G; GSK, Clinical Pharmacology and Experimental Medicine, 1250 South Collegeville Road, Collegeville, PA 19426, USA., Drewes G; Cellzome GmbH . A GSK Company, 69117 Heidelberg, Germany., Gamallo P; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Ghidelli-Disse S; Cellzome GmbH . A GSK Company, 69117 Heidelberg, Germany., Gresham S; GSK, David Jack Centre for R&D, Park Road, Ware, Hertfordshire SG12 ODP, UK., Jiménez E; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., de Mercado J; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Pérez-Herrán E; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Porras-De Francisco E; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Rullas J; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Casado P; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Leroux F; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France., Piveteau C; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France., Kiass M; National Reference Center for Tuberculosis and Mycobacteria, Sciensano, Brussels, Belgium., Mathys V; National Reference Center for Tuberculosis and Mycobacteria, Sciensano, Brussels, Belgium., Soetaert K; National Reference Center for Tuberculosis and Mycobacteria, Sciensano, Brussels, Belgium., Megalizzi V; Microbiology, Bioorganic and Macromolecular Chemistry, Facult. de Pharmacie, Universit. Libre de Bruxelles, Brussels, Belgium., Tanina A; Microbiology, Bioorganic and Macromolecular Chemistry, Facult. de Pharmacie, Universit. Libre de Bruxelles, Brussels, Belgium., Wintjens R; Microbiology, Bioorganic and Macromolecular Chemistry, Facult. de Pharmacie, Universit. Libre de Bruxelles, Brussels, Belgium., Antoine R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Brodin P; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France., Delorme V; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Moune M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Djaout K; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Slupek S; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Kemmer C; BioVersys AG, Basel, Switzerland., Gitzinger M; BioVersys AG, Basel, Switzerland., Ballell L; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Mendoza-Losana A; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Lociuro S; BioVersys AG, Basel, Switzerland., Deprez B; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France., Barros-Aguirre D; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Remuiñán MJ; GSK, Tres Cantos R&D, PTM, Tres Cantos, 28760 Madrid, Spain., Willand N; Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000 Lille, France., Baulard AR; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France.
Publikováno v:
Science translational medicine [Sci Transl Med] 2022 May 04; Vol. 14 (643), pp. eaaz6280. Date of Electronic Publication: 2022 May 04.